$2.69
0.04[1.51%]
Last update: 12:53PM Get Real Time Here
Aveanna Healthcare Hldgs
(NASDAQ:AVAH)Aveanna Healthcare Hldgs Stock (NASDAQ:AVAH), Analyst Ratings, Price Targets, Predictions
Aveanna Healthcare Holdings Inc has a consensus price target of $5.12, established from looking at the 38 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, JP Morgan, and Credit Suisse on March 18, 2024, December 13, 2023, and August 11, 2023. With an average price target of $1.33 between Deutsche Bank, JP Morgan, and Credit Suisse, there's an implied -50.43% downside for Aveanna Healthcare Holdings Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Deutsche Bank
JP Morgan
Credit Suisse
Truist Securities
RBC Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Aveanna Healthcare Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/18/2024 | Buy Now | 11.52% | Deutsche Bank | Pito Chickering | $2 → $3 | Maintains | Buy | Get Alert |
| 12/13/2023 | Buy Now | — | JP Morgan | Lisa Gill | — | Downgrade | Neutral → Underweight | Get Alert |
| 08/11/2023 | Buy Now | -62.83% | Credit Suisse | A.J. Rice | → $1 | Reiterates | Underperform → Underperform | Get Alert |
| 07/13/2023 | Buy Now | -36.8% | Truist Securities | David Macdonald | $1.4 → $1.7 | Maintains | Hold | Get Alert |
| 05/15/2023 | Buy Now | -25.65% | RBC Capital | Ben Hendrix | → $2 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/12/2023 | Buy Now | -62.83% | Credit Suisse | A.J. Rice | → $1 | Reiterates | Underperform → Underperform | Get Alert |
| 05/12/2023 | Buy Now | — | Raymond James | John Ransom | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 03/20/2023 | Buy Now | -25.65% | RBC Capital | Ben Hendrix | $3 → $2 | Maintains | Sector Perform | Get Alert |
| 03/20/2023 | Buy Now | 11.52% | Raymond James | John Ransom | $4 → $3 | Maintains | Strong Buy | Get Alert |
| 03/17/2023 | Buy Now | -47.96% | Truist Securities | David Macdonald | $1 → $1.4 | Maintains | Hold | Get Alert |
| 01/27/2023 | Buy Now | -62.83% | Credit Suisse | A.J. Rice | $2 → $1 | Downgrade | Neutral → Underperform | Get Alert |
| 11/21/2022 | Buy Now | 11.52% | RBC Capital | Frank Morgan | $7 → $3 | Downgrade | Outperform → Sector Perform | Get Alert |
| 11/17/2022 | Buy Now | -25.65% | Credit Suisse | A.J. Rice | $5.5 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 11/16/2022 | Buy Now | 48.7% | Raymond James | John Ransom | $6 → $4 | Maintains | Strong Buy | Get Alert |
| 11/11/2022 | Buy Now | -44.24% | Stephens & Co. | Scott Fidel | $2.25 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 08/19/2022 | Buy Now | 85.87% | Barclays | Sarah James | $7 → $5 | Maintains | Overweight | Get Alert |
| 08/15/2022 | Buy Now | 123.05% | Raymond James | John Ransom | $8 → $6 | Maintains | Strong Buy | Get Alert |
| 07/22/2022 | Buy Now | -7.06% | Jefferies | Brian Tanquilut | $9 → $2.5 | Downgrade | Buy → Hold | Get Alert |
| 07/05/2022 | Buy Now | — | Truist Securities | David Macdonald | — | Downgrade | Buy → Hold | Get Alert |
| 06/21/2022 | Buy Now | 30.11% | Stephens & Co. | Scott Fidel | $5.5 → $3.5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/31/2022 | Buy Now | 197.4% | Raymond James | John Ransom | $12 → $8 | Maintains | Strong Buy | Get Alert |
| 03/31/2022 | Buy Now | 234.57% | RBC Capital | Ben Hendrix | $16 → $9 | Maintains | Outperform | Get Alert |
| 03/30/2022 | Buy Now | 85.87% | Truist Securities | David Macdonald | $10 → $5 | Maintains | Buy | Get Alert |
| 03/30/2022 | Buy Now | 123.05% | Deutsche Bank | Pito Chickering | $12.5 → $6 | Maintains | Buy | Get Alert |
| 03/30/2022 | Buy Now | 160.22% | Stephens & Co. | Scott Fidel | $11.5 → $7 | Maintains | Overweight | Get Alert |
| 03/30/2022 | Buy Now | 160.22% | Barclays | Sarah James | $16 → $7 | Maintains | Overweight | Get Alert |
| 03/30/2022 | Buy Now | 253.16% | Credit Suisse | Nick Giovacchini | $12 → $9.5 | Maintains | Outperform | Get Alert |
| 03/29/2022 | Buy Now | 104.46% | B of A Securities | Joanna Gajuk | $10 → $5.5 | Downgrade | Buy → Neutral | Get Alert |
| 11/23/2021 | Buy Now | 346.1% | Raymond James | John Ransom | — | Maintains | Strong Buy | Get Alert |
| 05/24/2021 | Buy Now | 420.45% | JP Morgan | Lisa Gill | — | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Aveanna Healthcare Hldgs (AVAH)?
The latest price target for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was reported by Deutsche Bank on March 18, 2024. The analyst firm set a price target for $3.00 expecting AVAH to rise to within 12 months (a possible 11.52% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aveanna Healthcare Hldgs (AVAH)?
The latest analyst rating for Aveanna Healthcare Hldgs (NASDAQ: AVAH) was provided by Deutsche Bank, and Aveanna Healthcare Hldgs maintained their buy rating.
When was the last upgrade for Aveanna Healthcare Hldgs (AVAH)?
There is no last upgrade for Aveanna Healthcare Hldgs.
When was the last downgrade for Aveanna Healthcare Hldgs (AVAH)?
The last downgrade for Aveanna Healthcare Holdings Inc happened on December 13, 2023 when JP Morgan changed their price target from N/A to N/A for Aveanna Healthcare Holdings Inc.
When is the next analyst rating going to be posted or updated for Aveanna Healthcare Hldgs (AVAH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aveanna Healthcare Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aveanna Healthcare Hldgs was filed on March 18, 2024 so you should expect the next rating to be made available sometime around March 18, 2025.
Is the Analyst Rating Aveanna Healthcare Hldgs (AVAH) correct?
While ratings are subjective and will change, the latest Aveanna Healthcare Hldgs (AVAH) rating was a maintained with a price target of $2.00 to $3.00. The current price Aveanna Healthcare Hldgs (AVAH) is trading at is $2.69, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.